POZ

The Big Treatment Questions

When do experts recommend starting treatment and which antiretrovirals should you take first?
When should you change your treatments and which drugs should you switch to?
What is drug resistance?
Can you take a break from treatment?
& more.

Posted 1 month ago

7 notes

HIV treatment, antiretroviral, drugs, drug resistance, taking a break, treatment regimen, clinical trials, adherance,

Long-Acting PrEP Injection Prevents Anal Simian HIV Transmission

A long-acting, injectable version of the antiretroviral dolutegravir prevented rectal transmission of simian HIV (SHIV) in eight macaques.

Posted 2 months ago

3 notes

PrEP, HIV transmission, anal, simian, SHIV, antiretroviral, dolutegravir, macaques, National AIDS Treatment, Advocacy Project, simian HIV, pre-exposure prophylaxis,

ViiV Healthcare to Provide Low-cost Versions HIV Medicine to Countries in Need

ViiV Healthcare has granted a voluntary license to the Medicines Patent Pool (MPP) for pediatric formulations of the antiretroviral drug abacavir in 118 countries.

To read more, Click here.

Posted 2 months ago

3 notes

ViiV Healthcare, HIV, voluntary license, Medicines Patent Pool, MPP, low cost, ARV, antiretroviral, abacavir, medicines,

HIV Docs Believe Meds Prevent Transmission, But Don’t Start ARVs Early

HIV clinicians widely believe in the antiretroviral (ARV) treatment as prevention model, but they don’t necessarily apply the concept to individual patients, with only one in seven clinicians immediately starting treatment in patients, a new study has found.

Posted 5 months ago

2 notes

HIV, When to start, antiretroviral, AIDS,